Viral IL-10 gene therapy inhibits TNF-α and IL-1β, not IL-6, in the newborn endotoxemic mouse
- 31 March 1996
- journal article
- Published by Elsevier BV in Journal of Pediatric Surgery
- Vol. 31 (3), 411-414
- https://doi.org/10.1016/s0022-3468(96)90749-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Interleukin-6 elevation in critically ill infants with sepsis and necrotizing enterocolitisThe Journal of Pediatrics, 1994
- Neonatal Tumor Necrosis Factor, Interleukin-1α, Interleukin-1β, and Interleukin-6 Response to InfectionAmerican Journal of Perinatology, 1994
- ADENOVIRUS-MEDIATED GENE TRANSFER IN THE TRANSPLANT SETTINGTransplantation, 1994
- IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytesInternational Immunology, 1994
- Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceNature Genetics, 1993
- Modified Immunological Status of Anti-IL-10 Treated MiceCellular Immunology, 1993
- Gene Therapy of the Immune SystemAnnual Review of Immunology, 1993
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFIScience, 1990
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985